Liming Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liming Zhang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Jinghan Lin
Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150000, China
3 shared publicationsTingting Zhao
Department of Neurology, The First Affiliated Hospital of Harbin Medical University, China
3 shared publications- Jinghan Lin
Department of Neurology, First Affiliated Hospital of Harbin Medical University, No.23 Postal Street, Nangang District, Harbin, China
2 shared publications Lina Sun
Department of Neurology, The First Affiliated Hospital of Harbin Medical University, 23 Post Street, Harbin 150001, PR China
2 shared publicationsMeimei Yang
Department of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
2 shared publicationsTing Ju
Department of Neurology, The First Affiliated Hospital of Harbin Medical University, China
2 shared publications
Latest Publications
- Open Access
- 15 December 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1720389
Food-specific IgG-based elimination diet decreased IL-6, TNF-α, and CGRP and improved symptoms in adults with migraine
Background: Food-specific IgG antibodies have been proposed to be biomarkers to identify food that triggers an inflammation response. We aimed to evaluate the effect of a food-specific IgG-based elimination diet by assessing the changes in the symptoms of migraine and its comorbidities, inflammatory cytokines, neuropeptides, and neurotransmitters, and their correlation. Methods: This was a sham-controlled randomized trial. A total of 98 patients with migraine who had at least one positive food-specific IgG antibody were randomly assigned to either the true diet group (IgG-positive foods were excluded, n = 52) or the sham diet group (alternative IgG-negative foods were excluded, n = 46). At baseline and at the end of 12 weeks, seven questionnaires were administered regarding the symptoms of migraine, gastrointestinal symptoms, anxiety, depression, and sleep quality. Fourteen food-specific IgG antibodies, such as IL-6, IL-10, TNF-α, 5-HT, calcitonin gene-related peptide (CGRP), and vasoactive intestinal peptide (VIP), in serum were assessed using enzyme-linked immunosorbent assays. Results: At the end of 12 weeks, the true diet group had a larger reduction in questionnaires of migraine (except for MSQ), gastrointestinal symptoms, and poor sleeping, as well as food-specific positive IgG, IL-6, TNF-α, and CGRP in the serum. The difference in the change of “days with migraine in past 4 weeks” between the sham and true diet groups was significantly attenuated after adjusting for IL-6 and TNF-α. Conclusion: An IgG-positive food elimination diet improved migraine and its comorbidities and reduced IL-6, TNF-α, and CGRP, which might be associated with the alleviated systemic chronic inflammation and downregulation of the sensitivity of trigeminal nerve endings. Clinical trial registration: Chictr.org.cn , identifier ChiCTR2000039278.
- 15 December 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1720389
Open AccessFood-specific IgG-based elimination diet decreased IL-6, TNF-α, and CGRP and improved symptoms in adults with migraine
Background: Food-specific IgG antibodies have been proposed to be biomarkers to identify food that triggers an inflammation response. We aimed to evaluate the effect of a food-specific IgG-based elimination diet by assessing the changes in the symptoms of migraine and its comorbidities, inflammatory cytokines, neuropeptides, and neurotransmitters, and their correlation. Methods: This was a sham-controlled randomized trial. A total of 98 patients with migraine who had at least one positive food-specific IgG antibody were randomly assigned to either the true diet group (IgG-positive foods were excluded, n = 52) or the sham diet group (alternative IgG-negative foods were excluded, n = 46). At baseline and at the end of 12 weeks, seven questionnaires were administered regarding the symptoms of migraine, gastrointestinal symptoms, anxiety, depression, and sleep quality. Fourteen food-specific IgG antibodies, such as IL-6, IL-10, TNF-α, 5-HT, calcitonin gene-related peptide (CGRP), and vasoactive intestinal peptide (VIP), in serum were assessed using enzyme-linked immunosorbent assays. Results: At the end of 12 weeks, the true diet group had a larger reduction in questionnaires of migraine (except for MSQ), gastrointestinal symptoms, and poor sleeping, as well as food-specific positive IgG, IL-6, TNF-α, and CGRP in the serum. The difference in the change of “days with migraine in past 4 weeks” between the sham and true diet groups was significantly attenuated after adjusting for IL-6 and TNF-α. Conclusion: An IgG-positive food elimination diet improved migraine and its comorbidities and reduced IL-6, TNF-α, and CGRP, which might be associated with the alleviated systemic chronic inflammation and downregulation of the sensitivity of trigeminal nerve endings. Clinical trial registration: Chictr.org.cn , identifier ChiCTR2000039278.
- 7 September 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 630, 133-142
Circ_0021155 can participate in the phenotypic transformation of human vascular smooth muscle cells via the miR-4459/TRPM7 axis
- 7 September 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 630, 133-142
Circ_0021155 can participate in the phenotypic transformation of human vascular smooth muscle cells via the miR-4459/TRPM7 axis
- Open Access
- 1 December 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (24) , 800
The application of weighted gene co-expression network analysis in identifying key modules and hub genes associated with disease status in Alzheimer’s disease
Background: Alzheimer’s disease (AD) is the most common neurodegenerative condition that affects more than 15 million individuals globally. However, a predictive molecular biomarker to distinguish the different stages of AD patients is still lacking. Methods: A weighted gene co-expression network analysis (WGCNA) was employed to systematically identify the co-expressed gene modules and hub genes connected with AD development based on a microarray dataset (GSE1297) from the Gene Expression Omnibus (GEO) database. An independent validation cohort, GSE28146, was utilized to assess the diagnostic efficiency for distinguishing the different stages of AD. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and western blotting analysis were applied to examine the mRNA and protein level of GRIK1, respectively, in AD mice established with the expression of mutant amyloid precursor protein and wild type mice. The morphology of neurons was investigated using phalloidin staining. Results: We identified 16 co-expressed genes modules, with the pink module showing significant association with all three disease statuses [neurofibrillary tangle (NFT), BRAAK, and mini-mental state examination (MMSE)]. Enrichment analysis specified that these modules were enriched in phosphatidylinositol 3-kinase (PI3K) signaling and ion transmembrane transport. The validation cohort GSE28146 confirmed that six hub genes in the pink module could distinguish severe and non-severe AD patients [area under the curve (AUC) >0.7]. These hub genes might act as a biomarker and help to differentiate diverse pathological stages for AD patients. Finally, one of the hubs, GRIK1, was validated by an animal AD model. The mRNA and protein level of GRIK1 in the AD hippocampus was increased compared with the control group (NC) hippocampus. Phalloidin staining showed that dendritic length of the GRIK1 pCDNA3.1 group was shorter than that of the NC group. Conclusions: In summary, we systematically recognized co-expressed gene modules and genes related to AD stages, which gave insight into the fundamental mechanisms of AD progression and revealed some probable targets for the treatment of AD.
- 1 December 2019
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (24) , 800
Open AccessThe application of weighted gene co-expression network analysis in identifying key modules and hub genes associated with disease status in Alzheimer’s disease
Background: Alzheimer’s disease (AD) is the most common neurodegenerative condition that affects more than 15 million individuals globally. However, a predictive molecular biomarker to distinguish the different stages of AD patients is still lacking. Methods: A weighted gene co-expression network analysis (WGCNA) was employed to systematically identify the co-expressed gene modules and hub genes connected with AD development based on a microarray dataset (GSE1297) from the Gene Expression Omnibus (GEO) database. An independent validation cohort, GSE28146, was utilized to assess the diagnostic efficiency for distinguishing the different stages of AD. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and western blotting analysis were applied to examine the mRNA and protein level of GRIK1, respectively, in AD mice established with the expression of mutant amyloid precursor protein and wild type mice. The morphology of neurons was investigated using phalloidin staining. Results: We identified 16 co-expressed genes modules, with the pink module showing significant association with all three disease statuses [neurofibrillary tangle (NFT), BRAAK, and mini-mental state examination (MMSE)]. Enrichment analysis specified that these modules were enriched in phosphatidylinositol 3-kinase (PI3K) signaling and ion transmembrane transport. The validation cohort GSE28146 confirmed that six hub genes in the pink module could distinguish severe and non-severe AD patients [area under the curve (AUC) >0.7]. These hub genes might act as a biomarker and help to differentiate diverse pathological stages for AD patients. Finally, one of the hubs, GRIK1, was validated by an animal AD model. The mRNA and protein level of GRIK1 in the AD hippocampus was increased compared with the control group (NC) hippocampus. Phalloidin staining showed that dendritic length of the GRIK1 pCDNA3.1 group was shorter than that of the NC group. Conclusions: In summary, we systematically recognized co-expressed gene modules and genes related to AD stages, which gave insight into the fundamental mechanisms of AD progression and revealed some probable targets for the treatment of AD.
- Open Access
- 1 February 2016
- Published by Wiley in FEBS Letters
- Vol. 590 (4) , 520-532
TRPM7 channel regulates ox‐LDL‐induced proliferation and migration of vascular smooth muscle cells via MEK‐ERK pathways
Transient receptor potential melastatin 7 (TRPM7) plays a key role in the pathophysiological response of multiple cell types. However, the role of TRPM7 channels in ox‐LDL‐induced proliferation and migration of VSMC remains unclear. This study used the thoracic aorta VSMCs to explore the effects of ox‐LDL on cell proliferation and migration and to investigate the underlying molecular mechanisms and signaling pathways. Data demonstrated that ox‐LDL significantly increased TRPM7 activity, and induced VSMC proliferation and migration. VSMC proliferation and migration were inhibited by nonspecific TRPM7 blocker 2‐APB or synthetic siRNA targeting TRPM7. Furthermore, the phosphorylation of ERK1/2 and MEK1/2 associated with cell proliferation and migration decreased in TRPM7‐deficient VSMC. Therefore, TRPM7 may constitute a useful target for the treatment of atherosclerosis.
- 1 February 2016
- Published by Wiley in FEBS Letters
- Vol. 590 (4) , 520-532
Open AccessTRPM7 channel regulates ox‐LDL‐induced proliferation and migration of vascular smooth muscle cells via MEK‐ERK pathways
Transient receptor potential melastatin 7 (TRPM7) plays a key role in the pathophysiological response of multiple cell types. However, the role of TRPM7 channels in ox‐LDL‐induced proliferation and migration of VSMC remains unclear. This study used the thoracic aorta VSMCs to explore the effects of ox‐LDL on cell proliferation and migration and to investigate the underlying molecular mechanisms and signaling pathways. Data demonstrated that ox‐LDL significantly increased TRPM7 activity, and induced VSMC proliferation and migration. VSMC proliferation and migration were inhibited by nonspecific TRPM7 blocker 2‐APB or synthetic siRNA targeting TRPM7. Furthermore, the phosphorylation of ERK1/2 and MEK1/2 associated with cell proliferation and migration decreased in TRPM7‐deficient VSMC. Therefore, TRPM7 may constitute a useful target for the treatment of atherosclerosis.
- 1 August 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 463 (4) , 1297-1304
Genistein suppresses smooth muscle cell-derived foam cell formation through tyrosine kinase pathway
- 1 August 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 463 (4) , 1297-1304
Genistein suppresses smooth muscle cell-derived foam cell formation through tyrosine kinase pathway
- Open Access
- 24 February 2015
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 28 (9) , 1114-1120
A Combination of Intravenous Genistein Plus Mg2+Enhances Antihypertensive Effects in SHR by Endothelial Protection and BKCaChannel Inhibition
The effects of combining genistein (GST) plus magnesium (Mg) upon the development of hypertension were examined in 28 twelve-week-old male spontaneous hypertension rats (SHRs). Four experimental groups were tested: SHR (0.9% NaCl and DMSO), SHR + GST (0.9% NaCl and GST 5mg/kg/day), SHR + Mg (Mg2+ 0.75 mmol/kg/day and DMSO), and SHR + GST + Mg (Mg2+ 0.75 mmol/kg/day and GST 5mg/kg/day). A group of normotensive genetic control, Wistar-Kyoto (WKY) rats were also included for comparison. Drugs were administrated intravenously daily for 30 days. Systolic blood pressure (SBP) and heart rate were measured by tail-cuff plethysmography every five days. Vascular tone of mesenteric arteries was examined by an isometric force transducer. Big-conductance calcium-activated potassium channel (BKCa) currents were detected by whole-cell patch-clamp techniques. SBP in SHRs was significantly elevated vs. that in WKY rats. GST or Mg lowered SBP of SHRs. Their combination enhanced antihypertensive effects, as indicated by significantly lowered SBP and shorter onset times. GST or Mg individually improved endothelial dysfunction of SHRs. However, again their combination enhanced endothelial protection, nearly restoring maximal relaxation responses to those seen in WKY. BKCa currents in SHRs were increased compared with WKY rats. GST, Mg, and their combination restored BKCa currents to those of WKY rats. The combination of GST and Mg produces antihypertensive effects and improvement of endothelial dysfunction, which are substantially greater than that when either is used individually. These results suggest a novel and feasible protocol for the prevention and treatment of hypertension and related cardio- and cerebro-vascular diseases.
- 24 February 2015
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 28 (9) , 1114-1120
Open AccessA Combination of Intravenous Genistein Plus Mg2+Enhances Antihypertensive Effects in SHR by Endothelial Protection and BKCaChannel Inhibition
The effects of combining genistein (GST) plus magnesium (Mg) upon the development of hypertension were examined in 28 twelve-week-old male spontaneous hypertension rats (SHRs). Four experimental groups were tested: SHR (0.9% NaCl and DMSO), SHR + GST (0.9% NaCl and GST 5mg/kg/day), SHR + Mg (Mg2+ 0.75 mmol/kg/day and DMSO), and SHR + GST + Mg (Mg2+ 0.75 mmol/kg/day and GST 5mg/kg/day). A group of normotensive genetic control, Wistar-Kyoto (WKY) rats were also included for comparison. Drugs were administrated intravenously daily for 30 days. Systolic blood pressure (SBP) and heart rate were measured by tail-cuff plethysmography every five days. Vascular tone of mesenteric arteries was examined by an isometric force transducer. Big-conductance calcium-activated potassium channel (BKCa) currents were detected by whole-cell patch-clamp techniques. SBP in SHRs was significantly elevated vs. that in WKY rats. GST or Mg lowered SBP of SHRs. Their combination enhanced antihypertensive effects, as indicated by significantly lowered SBP and shorter onset times. GST or Mg individually improved endothelial dysfunction of SHRs. However, again their combination enhanced endothelial protection, nearly restoring maximal relaxation responses to those seen in WKY. BKCa currents in SHRs were increased compared with WKY rats. GST, Mg, and their combination restored BKCa currents to those of WKY rats. The combination of GST and Mg produces antihypertensive effects and improvement of endothelial dysfunction, which are substantially greater than that when either is used individually. These results suggest a novel and feasible protocol for the prevention and treatment of hypertension and related cardio- and cerebro-vascular diseases.